HYBRID EVENT: You can participate in person at Boston, Massachusetts, USA or Virtually from your home or work.

8th Edition of International Conference on Neurology and Brain Disorders

October 19-21, 2023

October 19 -21, 2023 | Boston, Massachusetts, USA

INBC 2023

Speaker at Neurology and Brain Disorders 2023 - Thomas J Webster
Keynote Presentation (In-Person)
Thomas J Webster, Interstellar Therapeutics, United States

Stem cells have not provided the universal, effective solution to neurological diseases that they were once thought to provide. In particular, maintaining stem cell viability during and after implantation into the brain has proved problematic. The use of enzymes (such as trypsin) [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Ulrich Sprick
Keynote Presentation (In-Person)
Ulrich Sprick, Alexius/Josef Clinic, Neuss, Germany

Dementia is still one of the most common serious psychiatric disorders in old age. A dementia of the Alzheimer's type is still considered to be a progressive irreversible disease which cannot be treated causally. However, in the meantime it has been shown that novel non-invas [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Ken Ware
Keynote Presentation (Virtual)
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia

Did the patient genetically inherit their complex psychophysical pathological condition/s or are they simply adopting and/or mirroring other members of their family who have the complex psychophysical condition that the patient is exhibiting? Over several decades it has been f [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Chongjie
Oral Presentation (In-Person)
Chongjie, Chongqing Medical University, China

Background: Traumatic brain injury (TBI) is a disease with high mortality and morbidity, which leads to severe neurological dysfunction. Neurogenesis has provided therapeutic options for treating TBI. Brain derived neurotrophic factor (BDNF) plays a key role in neuroblasts migra [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Didem Inanoglu
Oral Presentation (In-Person)
Didem Inanoglu, Franciscan Childrens, United States

Children with special health-care needs (CSHN) have or are at increased risk for chronic physical, developmental, behavioral, or emotional conditions and also require health and related services of a type or amount beyond that required by their peers. Acquired brain injury (ABI) [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Marina Martinez Vargas
Oral Presentation (In-Person)
Marina Martinez Vargas, Baylor College of Medicine, United States

Von Willebrand factor (VWF) is a multimeric protein that mediates thromboinflammation and has been linked to traumatic brain injury (TBI), specifically in the pathogenesis of early brain injury. Activated endothelium secretes VWF multimers as long hyperadhesive strings. During TB [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Teris Cheung
Oral Presentation (In-Person)
Teris Cheung, The Hong Kong Polytechnic University, Hong Kong

Transcranial pulse stimulation (TPS) has been proven effective to improve cognition, memory and depressive symptoms on Alzheimer’s disease, but supporting evidence on other neurological diseases or neuropsychiatric disorders remains limited. We aimed to investigate the effe [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Teris Cheung
Oral Presentation (In-Person)
Teris Cheung, The Hong Kong Polytechnic University, Hong Kong

Insomnia is a common health problem in the general population. There are different ways to improve sleeping habits and quality of sleep, however; there is no clinical trial using transdermal neurostimulation to treat individuals with symptoms of insomnia in Asia. This gave us the [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Eshani Mahajan
Oral Presentation (In-Person)
Eshani Mahajan, Postgraduate Institute of Medical Education and Research-PIGMER, India

IRL-1620 is a chemical entity that have neuroprotective activity as it increases growth factors VEGF and NGF. The Present study hypothesis is to evaluate the effect of IRL-1620 on Aß induced memory loss in the rat model of Alzheimer’s disease. We have taken 58 males a [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Farsana  F J
Oral Presentation (In-Person)
Farsana F J, Digital University Kerala, India

Oxygen extraction fraction (OEF) is a physiological biomarker reflecting the percentage of oxygen extracted from the blood supply, which is directly associated with cerebral oxygen metabolism. It can also provide information about the relative deficiencies in cerebral blood suppl [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Nikita Diwan
Oral Presentation (In-Person)
Nikita Diwan, King Georges's Medical University, India

Hyponatremia has been reported in various central nervous system infections like tuberculous meningitis and found to be associated with poor outcome. So far, no study has been conducted on hyponatremia in acute encephalitis syndrome (AES) in children. This study was planned to st [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Engy Asem Ashaat
Oral Presentation (In-Person)
Engy Asem Ashaat, National Research Centre, Egypt

Alopecia intellectual disability syndromes 4 (APMR4) is a very rare autosomal recessive condition caused by a mutation in  the LSS gene present on chromosome 21. This syndrome has a clinical heterogeneity mainly exhibited with variable degrees of intellectual disability (ID) [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Stephen Onyancha Kamanda
Oral Presentation (In-Person)
Stephen Onyancha Kamanda, Kenyatta National Hospital, Kenya

Scoliosis is commonly described as a 3D spinal deformity resulting in a curvature of 10 degress or more with a rotational spin. All the bones in the body have three cells that work together for the proper growth of the bone: The osteocyte,cell that coordinates the osseous work [....] » Read More

Speaker at Neurology and Brain Disorders 2023 -  Afsaneh Nikjooy
Oral Presentation (In-Person)
Afsaneh Nikjooy, Iran university of medical sciences, Iran (Islamic Republic of)

Background: Dyssynergic defecation (DD) is a major cause of chronic functional constipation. Patients with DD have greater psychological distress and impaired health-related quality of life compared with the general  population. This study aimed to evaluate the effectivene [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Mohamed Fathi Al Gharyani
Oral Presentation (In-Person)
Mohamed Fathi Al Gharyani, Benghazi Medical Center, Libyan Arab Jamahiriya

Background: Since the COVID-19 pandemic, many studies have reported severe neurologic effects of the infection on the brain. Intracerebral haemorrhage (ICH) is a particular pathology that can result in these devastating neurologic effects and affected patients are more likely to [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Nahom
Oral Presentation (In-Person)
Nahom, FelgeHiwot Referal Hospital, Ethiopia

The COVID-19 pandemic has caused an unprecedented impact on global health, affecting millions of people worldwide. In effect to tackling the devastating outcomes of the disease, the development of vaccines was the primary focus of health researchers worldwide. Thus, a few brands [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Mehdi Sheikhi
Oral Presentation (In-Person)
Mehdi Sheikhi, AJA University of Medical Sciences, Iran (Islamic Republic of)

Stroke is a leading cause of morbidity and second cause of mortality worldwide. Early participation in rehabilitation treatments such as neurostimulant drugs showed to be beneficial. Amantadine usually used as Parkinson disease treatment, is prescribed in patients with traumatic [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Navdeep Kaur
Oral Presentation (In-Person)
Navdeep Kaur, Cleveland Clinic Foundation, United States

Stroke is the second most common cause of cognitive impairment and dementia. Vascular dementia (VaD), a cognitive impairment following a stroke is common and substantially affects the quality of life. We recently demonstrated via gut microbe transplant studies that the gut microb [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Shayanthan Sornalingam
Oral Presentation (In-Person)
Shayanthan Sornalingam, Meditech International, Canada

Pseudobulbar affect (PBA), previously known as Pathologic Laughing and Crying (PLC) is a neurological disorder characterised by involuntary episodes of emotional expression, such as laughing or crying, that are disproportionate to the individual's current emotional state. Tho [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Eva Maria Gonzalez Diaz
Oral Presentation (In-Person)
Eva Maria Gonzalez Diaz, Cruces University Hospital, Spain

Objective: The clinical benefit of mechanical thrombectomy(MT) in acute ischemic stroke treatment, is correlated to the degree of reperfusion achieved. The First Pass Effect (FPE) is defined as complete/near revascularisation of the large-vessel occlusion [modified Thrombolysis [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Anish Ganesh
Oral Presentation (In-Person)
Anish Ganesh, The Dementia Project, United States

The symptoms of dementia often create a barrier between People Living with Dementia (PLWD) and their caregivers, which fuels a cycle of worsening outcomes for both parties. Care partners need a tool that alleviates this communication barrier to improve behavioral outcomes and qua [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Ahmed Abdelghyoum Mahgoub Mohamed
Oral Presentation (In-Person)
Ahmed Abdelghyoum Mahgoub Mohamed, Al-Neelain Institute for Medical Research, Sudan

Background: Caffeine’s wakefulness-promoting and sleep-disrupting effects are well established, yet whether caffeine affects human circadian timing is unknown. Also, Evidence suggests evening-type individuals have a higher risk of reporting psychological distress. However, [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Shima Algam Mohamd Musa
Oral Presentation (In-Person)
Shima Algam Mohamd Musa, Al-Neelain research institute, Sudan

Introduction: Circadian rhythms are regulated by genetic and environmental components. The association of intrinsic and extrinsic factor modulates physiological and individual sleep schedules sleep hygiene and even different chronotype. Evidence suggests evening-type individuals [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Magid Omer Mahmoud Abdalla
Oral Presentation (In-Person)
Magid Omer Mahmoud Abdalla, Al-Neelain Institute for Medical Research, Sudan

Background: Caffeine is one of the most widely consumed stimulants in the world , caffeine is commonly consumed to help offset fatigue, however, it can have several negative effects on sleep quality. Also chronotype are known to have an association with sleep quality . less stu [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Garima Kapur
Oral Presentation (In-Person)
Garima Kapur, Jaypee Institute of Information Technology, India

The human brain is able to adapt to new situations and learn new things. The purpose of the work is to investigate human brain adaptability and learning tendencies. The ability of the brain to learn, program, and adapt has been replicated using CMOS-based circuitry, Neuromorphic [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Christine Akumcha Tekum
Oral Presentation (In-Person)
Christine Akumcha Tekum, Maarif International School of Equatorial Guinea, Equatorial Guinea

There are many types of brain diseases, from injuries and infections to brain tumors. They can impact your ability to function and carry out daily activities. Outcomes vary widely depending on the type of brain disease, location and severity of the condition. The brain is [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Ram Prajit
Oral Presentation (In-Person)
Ram Prajit, Khon Kaen University, Thailand

Brain aging is related to oxidative stress that leads to neuronal apoptosis and cognitive dysfunction. Neurogenesis occurs throughout the lifespan in the subgranular zone of the hippocampal dentate gyrus and it is gradually reduced in brain aging. Long term administration of D-ga [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Pallavi Chatterjee
Oral Presentation (In-Person)
Pallavi Chatterjee, Saha Institute of Nuclear Physics, India

Neuromyelitis Optica Spectrum Disorder (NMOSD), is a rare auto-immune demyelinating disorder of the Central Nervous System. A circulating auto-antibody (AQP4-IgG) against aquaporin-4 (AQP4) is found in more than 80% patients. Other auto-antibodies like the one against Myelin ol [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Alex Goraltchouk
Oral Presentation (In-Person)
Alex Goraltchouk, Remedium Bio, United States

Objective: In this study, we aimed to directly compare the safety and efficacy potential of two novel investigational treatment regimens for cerebral ischemia - rhFGF18 and rhGDF11, using a model of ischemic stroke. Background: Despite recent advances in prevention and treat [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Rimsha Kaokab
Oral Presentation (In-Person)
Rimsha Kaokab, COMSATS, Pakistan

The neurological condition marked by memory loss and increasing cognitive deterioration is referred to as Alzheimer's disease (AD). Early and accurate detection of AD plays a crucial role in providing timely interventions and improving patient outcomes. In this thesis, we pro [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Fernanda Cristina Poscai Ribeiro
Oral Presentation (In-Person)
Fernanda Cristina Poscai Ribeiro, Universidade do Oeste Paulista, Brazil

Traumatic brain injury (TBI) is a leading cause of mortality and morbidity among individuals under 45 years of age worldwide. In the United States alone, approximately 1.7 million traumatic events occur annually, resulting in 50,000 deaths. This high prevalence of TBI poses a sig [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Mikaela Atkins
Poster Presentation (In-Person)
Mikaela Atkins, Arizona State University, United States

At one of the largest hospitals in Arizona, who care for individuals suffering from neurological diseases and houses a Joint Commission Comprehensive Stroke Center, the Comprehensive Stroke Program Quality Team has been working in conjunction with an Arizona State University Doct [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Carmen Vogt
Poster Presentation (In-Person)
Carmen Vogt, University of Nebraska Medical Center, United States

Restless Legs Syndrome (RLS) is associated with uncomfortable sensations in limbs that result in a sudden urge to move. The underlying etiology is unknown but is thought to be influenced by genetics, pregnancy, iron deficiency, and alterations in nerve hyperexcitability or inhibi [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Alicia C. Well
Poster Presentation (In-Person)
Alicia C. Well, University of California, Irvine School of Medicine, United States

Maternal tobacco use and nicotine exposure during pregnancy have been associated with adverse birth outcomes in infants and can lead to preventable pregnancy complications. Exposure to nicotine and other compounds in tobacco and electronic cigarettes (e-cigarettes) has been shown [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Ayako Fukuda
Poster Presentation (In-Person)
Ayako Fukuda, Dokkyo University, Japan

There are three types of Japanese characters: hiragana, katakana and kanji. Of these, hiragana is said to be easier to be acquired because of its regularity and one-to-one correspondence between letters and sounds (Uno et al., 2009). Therefore, early identification and support of [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Aliaa Mousa
Poster Presentation (In-Person)
Aliaa Mousa, Capital Health, United States

Introduction In the literature, there are not so many cases that connected Atherosclerosis to MMDandit hasn’t been assured by pathological studies as well. Moya Moya disease is a uniquecerebrovascular disease characterized by progressive large intracranial artery narrowing [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Neetika Sharma
Poster Presentation (In-Person)
Neetika Sharma, PGIMER, India

59 yrs old male presented with 11 months history of ataxia followed by 3 months history of bilateral hand action tremors. 9 month into illness he started to have cognitive decline followed by myoclonic jerks . He also had fragmented sleep with decreased total sleep duration. He h [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Amy Zhou
Poster Presentation (In-Person)
Amy Zhou, University of Saskatchewan, Canada

Introduction Chronic subdural hematoma (cSDH) is one of the most encountered conditions seen in neurosurgery. Although mainstay treatment of cSDH has been burr hole drainage, no consensus yet exists on optimal anesthesia technique for surgical treatment. Currently, the decision t [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Duaa Awad Ahmed Abdelsalam
Poster Presentation (In-Person)
Duaa Awad Ahmed Abdelsalam, University of Khartoum, Sudan

Motor Nerve conduction study is one of the electrophysiological tests performed to evaluate electrical conduction of motor nerves. Many studies involved nerve conduction velocity of peripheral nerves, but only few addressed this issue in relation to handedness with lots of contro [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Anna Siddiq
Poster Presentation (In-Person)
Anna Siddiq, VCOM - Auburn, AL, United States

Introduction: Hashimoto encephalopathy is a rare autoimmune condition characterized by symptoms such as confusion, seizures, and headache. It can lead to cerebral vasculitis causing the blood vessels in the brain to become inflamed and lead to decreased blood flow with potential [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Hari Om Vaja
Poster Presentation (In-Person)
Hari Om Vaja, B.J. Medical College, India

The discussion during the presentation will be of a case of a 5-year-old male child diagnosed with Crouzon syndrome and complex craniosynostosis, which involved the fusion of multiple sutures, including metopic, bi-coronal, sagittal, and lambdoid. Karyotyping showed no mutations [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Abigail C. Hasan
Poster Presentation (In-Person)
Abigail C. Hasan, Jamaica Hospital, United States

Background: Thrombolytic therapy has been the gold standard for treatment of ischemic stroke since 1996. While alteplase (tPA) remains the only FDA-approved thrombolytic for acute ischemic stroke, recent studies suggest that tenecteplase (TNK) may be a preferable alternative bec [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Vatsala Kapoor
Poster Presentation (In-Person)
Vatsala Kapoor, Medical College of Georgia, United States

Purpose: To review the optimal treatment of EGFR-mutant non-small cell lung cancer (NSCLC) that has progressed to leptomeningeal disease (LMD) through a rare case presentation and literature review. Background: LMD, the spread of cancer into the leptomeninges, is a rare compli [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Edlira Shemsi (Harizi)
Poster Presentation (In-Person)
Edlira Shemsi (Harizi), Regional Hospital Durres, Albania

SARSCoV2 the virus responsible for the COVID19 pandemic had not only respiratory symptoms,butalso neurological symptoms, and headache is a frequent complaint.Pathophysiologyof headache in the context of COVID 19 has some mechanisms that can be involved in persistence of headache [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Nadiah Ghazalli
Poster Presentation (In-Person)
Nadiah Ghazalli, GSK Pharmaceuticals Sdn Bhd, Malaysia

Active epilepsy among women of childbearing age is more prevalent compared to the general population worldwide. Women with epilepsy (WWE) face specific challenges related to hormonal function, and by extension, their sexual and reproductive health. The impact of epilepsy and anti [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Jariya Umka Welbat
Poster Presentation (In-Person)
Jariya Umka Welbat, Khon Kaen University, Thailand

Memory loss is the most common symptom found in aging. Studies of brain aging have revealed upregulation of the reactive oxygen species levels, which induce oxidative stress, neuronal damage, and neuronal apoptosis linked to memory decline. In animal studies, Dgalactose (D-gal) c [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Apiwat Sirichoat
Poster Presentation (In-Person)
Apiwat Sirichoat, Khon Kaen University, Thailand

L-methionine (L-met) is one of the nine essential amino acids. A high dose of supplementary methionine administration over a long period can promote oxidative stress due to increasing base levels of metabolites, such as homocysteine (Hcy). Homocysteine contributes to neuronal cel [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Noor Abdulhameed
Poster Presentation (In-Person)
Noor Abdulhameed, The University of Toledo College of Medicine & Life Sciences, United States

Parkinson’s disease (PD) is a progressive neurological movement disorder, with idiopathic onset, that impairs activities of daily living with nearly 10 million individuals diagnosed worldwide according to the Parkinson’s Foundation. Underlying pathology manifests du [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - David Joseph Sperbeck
Keynote Presentation (Virtual)
David Joseph Sperbeck, Private practice, United States

Recovery from brain trauma is in part dependent upon the brain’s ability to adapt to new and challenging experiences.  The brain’s capacity to structurally and functionally reorganize nerve cells and spontaneously develop new neuronal networks defines neuroplasti [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Rocco Gennaro
Keynote Presentation (Virtual)
Rocco Gennaro, University of Southern Indiana, United States

In this talk I first review several different notions of the “unity of consciousness” such as subject unity, object unity, spatial unity, and perhaps most common “phenomenal unity” which is the general notion that, from the first-person point of view, we e [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - W S El Masri
Keynote Presentation (Virtual)
W S El Masri, Keele University, United Kingdom

Traumatic spinal cord injuries (TSCI) are life-changing events from medical, physical, psychological, social, financial, vocational, environmental & matrimonial effects. The combination of consequent generalised physiological impairment, multi-system malfunction, multiple dis [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Brandon Lucke Wold
Oral Presentation (Virtual)
Brandon Lucke Wold, University of Florida, United States

Subarachnoid Hemorrhage (SAH) continues to be a leading cause of morbidity and mortality, with cerebral vasospasm as a common etiology of worse clinical progression. The purpose of this study was to evaluate and review the current literature concerning the effective treatment of [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Chathura Siriwardhana
Oral Presentation (Virtual)
Chathura Siriwardhana, University of Hawaii, United States

Background: There is an expanding body of literature implicating heart disease and stroke as a risk factor for Alzheimer disease (AD), highlighting significant pathways. Hawaii state has the most diverse ethnic population in the US and there exists significant racial health dis [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Swetha Ravi
Oral Presentation (Virtual)
Swetha Ravi, Michigan State University, United States

In temporal lobe epilepsy, the ability of the dentate gyrus to limit excitatory cortical input to the hippocampus breaks down, leading to seizures. The dentate gyrus is also thought to help discriminate between similar memories by performing pattern separation, but whether epilep [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Anne Dorothee Rosch
Oral Presentation (Virtual)
Anne Dorothee Rosch, University of Edinburgh, United Kingdom

Background:  Parkinson´s Disease (PD) is a progressive neurodegenerative disease manifesting itself in motor and nonmotor symptoms. With disease progression, cognitive deficits ranging from mild cognitive impairment (MCI) to dementia (Galtier et al., 2016) as well as [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Alexis Tang
Oral Presentation (Virtual)
Alexis Tang, University of Edinburgh, United Kingdom

Endovascular coiling (EC) has been identified in systematic reviews and meta-analyses to produce more favourable clinical outcomes in comparison to neurosurgical clipping (NC) when surgically treating a subarachnoid haemorrhage from a ruptured aneurysm. Cost-effectiveness analyse [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Georgios Matis
Oral Presentation (Virtual)
Georgios Matis, University Cologne Hospital, Germany

Ziconotide is a synthetic, water-soluble cone snail venom-derived peptide with a molecular weight of 2,639 Daltons. It is a nonopioid analgesic that selectively binds to N-type voltage-sensitive calcium channels on primary nociceptive afferent nerves in the dorsal horn of the spi [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Ravariu Cristian
Oral Presentation (Virtual)
Ravariu Cristian, Universitatea Politehnica Bucuresti, Romania

The human body tumour lesions are almost ordinary events in its life. Almost every people has moles. The moles are in fact small tumours, which normally doesn’t grow but in certain condition, triggered say by mechanical or radioactive events may become to have an uncontroll [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Lama Saad El Din Mahmoud
Oral Presentation (Virtual)
Lama Saad El Din Mahmoud, October 6 University, Egypt

Background: People with neglect suffer from various spatial deficits in several modalities, which in many cases impair everyday functioning. Virtual reality (VR) is a form of interaction between humans and computers in which a real or imaginary environment is simulated. Users in [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Ammar Aljabri
Oral Presentation (Virtual)
Ammar Aljabri, King Saud Bin Abdulaziz University for Health and Sciences, Saudi Arabia

Introduction: Mild Traumatic Brain Injury (mTBI) or concussion is a common yet undermanaged and underreported condition. This systematic review and meta-analysis aim to determine the efficacy of Vestibular Rehabilitation Therapy (VRT) as a treatment option for mTBI. Methods: [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Ilse Ivonne Saldivar Ruiz
Oral Presentation (Virtual)
Ilse Ivonne Saldivar Ruiz, Pain and Headache Centers of Texas, United States

Creutzfeldt–Jakob disease (CJD) is a rare form of rapidly progressive, neurodegenerative disease that results from the misfolding and accumulation of an aberrant, disease-associated prion protein (PrPD). CJD affects 1–1.5 cases per million per year with the sporadic-t [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Arwa Nogdalla
Oral Presentation (Virtual)
Arwa Nogdalla, Al-Neelain Institute for Medical Research, Sudan

Background: Daytime sleepiness is defined as the uncontrollable drowsiness during daytime that can interfere with performing daily activities and psychomotor performance. Poor sleep quality and bad sleep behaviors have a large contribution to the prevalence of daytime sleepiness [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Joao Rafael Rocha da Silva
Oral Presentation (Virtual)
Joao Rafael Rocha da Silva, Connect life rehabilitation and performance, Brazil

Pain is one of the most frequent complaints of patients, being responsible for causing damage to the public health system, disability, and loss of functionality to patients. Understanding the different levels and types of Pain and its possible musculoskeletal dysfunctions is ess [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Kledisa Shemsi
Oral Presentation (Virtual)
Kledisa Shemsi, Bezirkskliniken Schwaben, Germany

Background and Aims: To see the patients presented in the Emergency Department of SRD with headache as a symptom of COVID-19. Methods: We have seen frequency and characteristic of headache in 180 patients in an emergency with a test of polymerase chain reaction positive. [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Saryah Alhejazi
Oral Presentation (Virtual)
Saryah Alhejazi, University of Manchester, United Kingdom

Introduction: The COVID-19 pandemic has had a significant impact on healthcare systems all over the world. Concerns have been expressed regarding the potential for diagnostic and therapeutic delays in diseases such as cancer because of this. The delays in hospital admissions and [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Yang Du
Oral Presentation (Virtual)
Yang Du, Shanghai Mental Health Centre, Shanghai Jiao Tong University School of Medicine, China

Background: Depressive symptoms are common in Alzheimer's disease (AD) and are associated with cognitive function.  Amygdala functional connectivity (FC) and radiomic features related to depression and cognition.  However, studies have yet to explore the neural mec [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Robert Euro Djojoseputro
Oral Presentation (Virtual)
Robert Euro Djojoseputro, Udayana University, Indonesia

Central Post Stroke Pain (CPSP) is a form of chronic neuropathic pain presenting in 8-55% of patients within the first year after their first-stroke incident. The wide range of CPSP prevalence is due to the nature of CPSP onset and also lack of standardised diagnostic tool for CP [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Nicole Cruse
Oral Presentation (Virtual)
Nicole Cruse, Sacred Heart University, United States

Traumatic brain injury (TBI) is one of the leading causes of death and disability globally and results in an array of deficits that can be extremely difficult to diagnose and treat due to their heterogeneity. Individuals with TBI often live with permanent emotional, physical, and [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Seham Azzam
Poster Presentation (Virtual)
Seham Azzam, TTUHSC School of Medicine, United States

Alzheimer’s disease (AD) is a neurodegenerative disease that causes cognitive impairment, characterized by progressive cognitive decline, memory loss, and neuronal death in the cerebral cortex, hippocampus, and other brain regions. Hallmarks of its pathology are amyloid bet [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Daniel Zahedi
Poster Presentation (Virtual)
Daniel Zahedi, Cambridge University, United Kingdom

Background: There is an unmet need for providing physical healthcare to older adults who are psychiatric inpatients, despite high levels of comorbidity and mortality. Although liaison services in acute hospitals are now the norm, the reverse is not usually available for patients [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Hash Brown Taha
Poster Presentation (Virtual)
Hash Brown Taha, University of California Los Angeles, United States

Parkinsonian disorders, including Parkinson's disease (PD), multiple system atrophy (MSA), dementia with Lewy bodies (DLB), progressive supranuclear palsy (PSP), and corticobasal syndrome (CBS), present shared early motor symptoms but differing cellular and regional pathophys [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Thamer H Alsharif
Poster Presentation (Virtual)
Thamer H Alsharif, The Royal College of Surgeons, Ireland

Introduction: We present a case of a 47-year-old female who had a painless soft mass on her scalp misdiagnosed as a trichilemmal cyst instead of dermatofibroma protuberans. Case Presentation: In January 2021, a woman presented to a clinic with a headache and swelling on the [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Johny Tran
Poster Presentation (Virtual)
Johny Tran, Temecula Valley Hospital, United States

Introduction: Leucine-rich glioma-inactivated 1 (LGI1)-antibody encephalitis can be difficult to diagnose. It should be considered when there is clinical presentation of brief, unilateral jerking of the face and arm, termed faciobrachial dystonic seizures (FBDS), which is a hall [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Yaman Dalati
Poster Presentation (Virtual)
Yaman Dalati, Michigan State University, United States

Neuralgic amyotrophy, or Parsonage-Turner syndrome (PTS), is a rare autoimmune inflammatory disorder of the brachial plexus. Patients will present with episodes of extreme shoulder pain with eventual development of paresis and atrophy of the innervated muscle. These symptoms may [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Pranav Reddy
Poster Presentation (Virtual)
Pranav Reddy, Rowan-Virtua School of Osteopathic Medicine, United States

Background:  Traumatic Brain Injury (TBI) is an injury to the brain caused by a blow to the head, which is commonly seen in motor vehicle accidents, sports injuries, falls, and assaults. Studies have shown that emotional states such as agitation can result in a longe [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Arieh Sorin Solomon
Poster Presentation (Virtual)
Arieh Sorin Solomon, Tel Aviv University, Israel

In humans, carotid stenosis of 70% and above might be the cause of clinical symptoms such as transient ischemic attack and stroke. No clinical or animal studies have evaluated mild carotid occlusion, and few examined unilateral occlusion. Here, Wistar rats underwent bilateral or [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Jaskeerat Gujral
Poster Presentation (Virtual)
Jaskeerat Gujral, University of Pennsylvania, United States

Background: Parkinson’s disease (PD) is a chronic neurodegenerative disease affecting more than 10 million people worldwide. PD is commonly associated with motor symptoms like bradykinesia and non-motor symptoms like autonomic changes. Oftentimes, these symptoms can be rec [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Jaskeerat Gujral
Poster Presentation (Virtual)
Jaskeerat Gujral, University of Pennsylvania, United States

Background: Parkinson’s disease (PD) is a chronic neurodegenerative disease affecting more than 10 million people worldwide. PD is commonly associated with motor symptoms like bradykinesia and non-motor symptoms like autonomic changes. Oftentimes, these symptoms can be rec [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Drake Shafer
Poster Presentation (Virtual)
Drake Shafer, Temecula Valley Hospital, California University of Science and Medicine, United States

Transverse myelitis is a rare but documented sequela of heroin use. While the underlying etiology is not clearly elucidated, the prevailing pathophysiologic mechanism amongst existing literature suggests an immune mediated hypersensitivity reaction due to heroin insufflation fo [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Stephen Avila
Poster Presentation (Virtual)
Stephen Avila, Cedars Sinai Medical Center, United States

Summary/Objective: To describe a patient who developed refractory vestibular migraine after a motor vehicle accident (MVA) and COVID-19 infection with subsequent improvement while on multiple CGRP antagonists with off-label dosing and to provide support for the role of CGRP in v [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Sandeep Ghosh
Poster Presentation (Virtual)
Sandeep Ghosh, Accord Superspeciality Hospital, India

Cryptococcus neoformans infection predominantly occurs in the immunocompromised patients. However, it may infect apparently immunocompetent hosts and present as stroke mimic. We are reporting a case of elderly gentleman who presented with acute onset right upper limb weakness, at [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Jinwon Chang
Poster Presentation (Virtual)
Jinwon Chang, Korean Minjok Leadership Academy, Korea, Republic of

Frontotemporal dementia (FTD) is the second most common form of presenile dementia; however, its diagnosis has been poorly investigated. Previous attempts to diagnose FTD using quantitative electroencephalography (qEEG) have yielded inconsistent results in both spectral and funct [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Badria Alayidi
Poster Presentation (Virtual)
Badria Alayidi, University of Nottingham, United Kingdom

Multiple sclerosis (MS), a debilitating inflammatory disease of the central nervous system, afflicts approximately 2.5 million people worldwide. Manifesting through a variety of symptoms including gait and balance impairments, the progression of MS notably exacerbates balance dif [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Yusor Al-Nuaimy
Poster Presentation (Virtual)
Yusor Al-Nuaimy, Ajman University, United Arab Emirates

Current literature shows that the thalamus plays an indirect (secondary) role in epileptogenesis. However, till date, the question of the thalamus being a primary seizure generator remains unanswered. This study aimed to determine the primary role of the thalamus in epileptogenes [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Sushanta Paudel
Oral Presentation (Virtual)
Sushanta Paudel, Nepalese Army Institute of Health Sciences, Nepal

Background and purpose: SWI can help in the diagnosis of thrombus within the vessel in acute ischemic stroke (AIS) known as susceptibility vessel sign (SVS) and detection of SVS within the vessel can predict treatment modality and outcome. In this study, the purpose is to correl [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Deepa Khanal
Oral Presentation (Virtual)
Deepa Khanal, Manipal College of Medical Sciences, Nepal

Introduction: We present a case of pseudoaneurysm of the facial artery after tonsillectomy managed with successful endovascular coiling. Presentation of Case: 41-year-old lady presented with a history of throat pain and 3 episodes of hematemesis on the 3rd, 4th, and 7th post [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Rachel Johansson
Poster Presentation (Virtual)
Rachel Johansson, UC Davis School of Medicine, United States

Introduction: Infantile Neuronal Ceroid Lipofuscinosis (INCL, also known as CLN1 Batten Disease, or CLN1) is a rare, devastating neurodegenerative disease affecting infants and children.  CLN1 is caused by mutations in the CLN1 gene, which encodes the enzyme palmitoyl-prote [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - David Zeng
Poster Presentation (Virtual)
David Zeng, Johns Hopkins University, United States

Previous work in humanized mouse models of human immunodeficiency virus type-1 (HIV-1) has demonstrated that knocking down the matricellular protein Osteopontin (OPN) in vivo leads to a robust increase in the expression of proinflammatory markers TSPO and AIF-1, suggesting that O [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Kaviya Devaraja
Poster Presentation (Virtual)
Kaviya Devaraja, University of Toronto, Canada

Glioblastoma (GBM) is a fatal brain cancer in adults with ineffective existing treatment methods. Cell adhesion molecules (CAMs) are proteins that are expressed on the surface of cells and enable them to communicate and interact with one another and the surrounding environment. I [....] » Read More

Speaker at Neurology and Brain Disorders 2023 -  Daniel Clayman
Poster Presentation (Virtual)
Daniel Clayman, University of Nottingham, United Kingdom

M80T mutation of triose phosphate isomerase (TPI) presents one potential contributory pathway for developing Alzheimer’s disease (AD). M80T effects the triose phosphate isomerase (TPI) enzyme activity within the glycolysis pathways producing enhanced levels of methylglyoxal [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Andre Augusto Ceballos Melo
Poster Presentation (Virtual)
Andre Augusto Ceballos Melo, Hospital Sao Francisco, Brazil

Design to facilitate the recognition of congruent prosthetic movements, context-to-motion translations guided by image, verbal prompt, users nonverbal communication as facial expressions, gestures, paralinguistics, scene context and object recognition contributes to this process& [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Chen Xuemei
Poster Presentation (Virtual)
Chen Xuemei, Chengdu Fourth People's Hospital, China

Studies have shown differences in neuropsychiatric symptoms (NPSs) of Alzheimer’s disease?AD? between the males and females. However, we do not know whether this difference is influenced by disease severity. Method:  Patients with AD who visited the Memory Cl [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Huicong Wang
Poster Presentation (Virtual)
Huicong Wang, Capital Medical University, China

Objective: Generalized anxiety disorder (GAD) is a typical multisystem disease characterized by decreased activity in the left dorsolateral prefrontal cortex (DLPFC). Transcranial near-infrared stimulation (tNIRS) was used to stimulate the left DLPFC to relieve anxiety, and tran [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Sushanta Paudel
Poster Presentation (Virtual)
Sushanta Paudel, Nepalese Army Institute of Health Sciences, Nepal

Introduction: We present a case of chronic subdural hematoma refractory to burr hole surgery treated successfully with middle meningeal artery embolization. Presentation of Case: 61-year-old gentleman presented with a history of headaches and single episodes of vomiting. Ne [....] » Read More

Speaker at Neurology and Brain Disorders 2023 - Mohammad Aadil Qamar
Poster Presentation (Virtual)
Mohammad Aadil Qamar, Ziauddin University, Pakistan

Background: Intramedullary spinal cord ependymomas (IMSCE) are rare tumors that mostly occur in adult patients. Management strategies and related outcomes are heterogeneously reported across the literature, demanding a comprehensive analysis to standardize guidelines. We system [....] » Read More

Watsapp